ARS Pharmaceuticals Balance Sheet (2020-2026) | SPRY

Balance Sheet Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Assets
Current Assets
Cash & Equivalents (Quarter)
359.69M300.66M60.06M233.99M218.69M203.22M210.52M87.86M119.02M60.53M70.97M56.01M36.63M39.66M50.82M39.86M51.54M59.56M41.32M24.32M
Short-term Investments (Quarter)
19.86M39.28M63.40M63.86M176.69M133.19M181.37M157.39M167.63M182.12M164.97M263.20M235.86M188.59M228.65M203.67M176.65M
Cash & Current Investments (Quarter)
359.69M300.66M60.06M253.85M257.98M266.62M274.38M264.55M252.21M241.90M228.36M223.63M218.74M204.62M314.02M275.73M240.13M288.21M244.99M200.97M
Receivables - Net (Quarter)
0.77M8.18M9.30M25.13M36.45M25.35M28.66M
Receivables - Other (Quarter)
0.16M0.21M0.31M0.35M0.21M0.65M0.28M0.12M0.15M1.23M0.96M2.03M4.27M
Receivables (Quarter)
0.65M0.93M9.41M10.27M27.15M40.72M25.35M28.66M
Raw Materials (Quarter)
0.42M
Work In Process (Quarter)
0.29M
Finished Goods (Quarter)
5.21M7.27M
Inventory (Quarter)
0.71M5.21M7.27M8.74M7.78M8.37M8.82M
Prepaid Assets (Quarter)
3.34M4.70M7.49M5.15M4.17M0.77M1.05M0.87M2.56M1.12M0.69M0.40M0.14M6.89M8.34M1.01M1.28M6.19M6.79M
Current Assets (Quarter)
363.03M305.36M60.73M261.33M263.13M270.80M277.70M267.35M255.03M244.47M231.73M226.24M220.74M208.79M334.30M303.86M281.44M338.86M284.90M245.24M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)
1.98M1.91M0.07M2.43M2.48M0.01M0.33M0.58M0.59M0.62M0.57M0.62M0.64M0.84M1.07M1.07M1.07M1.21M2.46M2.29M
Long-Term Investments (Quarter)
39.94M64.78M43.97M24.22M
Intangibles (Quarter)
0.62M0.53M0.45M7.50M7.37M7.24M0.19M14.73M14.45M14.18M
Goodwill & Intangibles (Quarter)
0.62M7.37M7.24M0.19M14.73M14.45M14.18M
Long-Term Deferred Tax (Quarter)
29.04M36.86M73.41M
Other Non-Current Assets (Quarter)
0.35M0.35M0.02M0.25M0.25M2.40M2.94M2.84M0.14M0.69M0.02M0.53M0.45M3.11M3.13M3.05M2.92M2.79M2.65M
Non-Current Assets (Quarter)
3.95M47.21M0.72M51.14M30.87M0.27M3.73M3.84M3.72M4.09M1.46M1.34M1.23M8.81M16.86M23.46M32.04M33.94M42.76M42.34M
Assets (Quarter)
366.98M352.56M61.45M312.47M294.00M271.06M281.44M271.19M258.75M248.56M233.19M227.58M221.97M217.60M351.15M327.32M313.47M372.80M327.65M287.57M
Liabilities
Current Liabilities
Accounts Payables (Quarter)
1.80M1.72M3.11M2.63M2.11M0.13M4.93M9.60M9.82M10.95M2.15M3.50M6.57M16.52M9.87M27.01M44.26M1.68M5.72M5.84M
Notes Payables (Quarter)
3.48M
Payables (Quarter)
1.80M1.72M6.59M2.63M2.11M0.13M4.93M9.60M9.82M10.95M2.15M3.50M6.57M16.52M9.87M27.01M44.26M1.68M5.72M5.84M
Accumulated Expenses (Quarter)
9.66M3.28M6.53M0.40M0.60M0.28M12.00M1.85M11.27M6.88M20.41M
Other Accumulated Expenses (Quarter)
0.04M3.08M0.59M0.59M
Short term Debt (Quarter)
Current Leases (Quarter)
0.96M1.09M0.14M1.12M0.88M0.21M0.23M0.23M0.23M0.23M0.24M0.22M0.16M0.10M0.04M0.07M0.59M0.58M
Current Deferred Revenue (Quarter)
1.46M3.14M0.01M3.10M0.56M0.54M0.75M0.53M0.61M0.76M
Total Current Liabilities (Quarter)
15.55M15.35M8.19M14.81M11.14M3.99M5.44M9.84M10.05M11.18M2.39M3.71M6.72M16.62M23.44M27.62M45.60M50.88M39.15M49.61M
Non-Current Liabilities
Non-Current Debt (Quarter)
4.93M
Non-Current Deffered Revenue (Quarter)
3.00M2.85M1.53M1.34M1.10M1.27M1.13M0.98M
Preferred Stock Liabilities (Quarter)
54.81M
Operating Leases (Quarter)
1.78M5.08M0.48M4.43M4.07M0.25M0.20M0.15M0.09M0.04M1.07M0.95M
Other Non-Current Liabilities (Quarter)
0.08M1.42M3.78M4.61M4.48M
Total Non-Current Liabilities (Quarter)
16.59M8.55M94.36M119.73M221.37M208.79M221.78M
Total Liabilities (Quarter)
17.33M20.43M16.68M19.24M15.21M3.99M8.55M10.04M10.20M11.27M2.43M3.71M6.72M16.62M94.36M98.34M121.15M225.15M213.39M226.26M
Shareholder's Equity
Total Debt (Quarter)
4.93M
Common Equity (Quarter)
349.65M332.13M-31.27M-38.26M-44.03M-50.16M272.89M261.15M248.55M237.28M230.76M223.87M215.24M200.98M256.80M228.97M192.32M147.66M114.26M61.31M
Shareholder's Equity (Quarter)
349.65M332.13M-31.27M-38.26M-44.03M-50.16M272.89M261.15M248.55M237.28M230.76M223.87M215.24M200.98M256.80M228.97M192.32M147.66M114.26M61.31M
Liabilities and Shareholders Equity (Quarter)
366.98M352.56M61.45M312.47M294.00M271.06M281.44M271.19M258.75M248.56M233.19M227.58M221.97M217.60M351.15M327.32M313.47M372.80M327.65M287.57M
Retained Earnings (Quarter)
-140.10M-162.80M-210.84M-230.27M-1.62M0.41M-91.90M-109.27M-0.16M0.05M-0.12M-0.14M-173.24M-123.31M0.07M-202.13M-253.28M0.12M-355.22M